The most recognized aspect of these interactions is cancer cell adhesion to the peritoneum, which has been found to be controlled by the binding of cancer cell surface ligand CD43 to the HPMC-derived intercellular adhesion molecule-1 (ICAM-1) [8, 9]. Here, ICAM1 is linked to cancer.